Canacord's take on the EIB's "under appraisal" funding and how it fits in with what else looks lined up, and what's left to find...
The €500m of debt funding announced today accompanies an existing A$200m (~€120m)of debt funding indication from Export Finance Australia (see note) and provides ~50% of the €1,399m funding requirement for the ZCLP, on an indicative basis. If Nobian elects to form a JV with VUL for the Central Lithium Plant (50% capital contribution of €179m see note), and with the German Government signalling that it may contribute 40% of geothermal costs (CGe €272m), it leaves a €328m funding gap before any sell-down of the project (excl. €78.6m in cash). The company continues to sound out strategic investors for equity funding, targeting indicative offers in the first half of 2024. If VUL is able to achieve a sell-down, with capital commitment, we believe a manageable funding gap could be delivered.
Yes, CAPEX is a big number, but already the ducks are lining up well.
Read the rest here... and acknowledgements to anyone who previously posted this
CG_23.02_24.pdf (v-er.eu)
- Forums
- ASX - By Stock
- VUL megathread
Canacord's take on the EIB's "under appraisal" funding and how...
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VUL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.53 |
Change
0.130(3.82%) |
Mkt cap ! $600.5M |
Open | High | Low | Value | Volume |
$3.42 | $3.54 | $3.37 | $1.602M | 461.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3262 | $3.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.32 | 30022 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2231 | 3.520 |
3 | 1389 | 3.510 |
4 | 7007 | 3.500 |
6 | 17750 | 3.490 |
4 | 19495 | 3.480 |
Price($) | Vol. | No. |
---|---|---|
3.530 | 899 | 2 |
3.540 | 13942 | 6 |
3.550 | 25932 | 8 |
3.560 | 3633 | 3 |
3.570 | 2000 | 1 |
Last trade - 15.59pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$3.52 |
  |
Change
0.130 ( 3.40 %) |
|||
Open | High | Low | Volume | ||
$3.45 | $3.54 | $3.38 | 42643 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
VUL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online